Results 81 to 90 of about 5,401 (225)

Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis

open access: yes, 2004
BACKGROUND: This report investigates the effect of pimecrolimus cream 1% (Elidel, Novartis pharma AG, Basel, Switzerland), a nonsteroid, cell-selective, cytokine inhibitor on the course of atopic dermatitis (AD), as assessed by changes in body surface ...
L. Puig   +10 more
core   +1 more source

Functional Genetic Variation in Ubiquitin D Promoter Influences Susceptibility to Atopic Dermatitis

open access: yes
Clinical &Experimental Allergy, Volume 56, Issue 10, Page 1237-1239, October 2026.
Yi Ying Eliza Lim   +5 more
wiley   +1 more source

Reproxalap ‐ A Novel Treatment Option for Allergic Conjunctivitis – A Comprehensive Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Allergic conjunctivitis is a prevalent, immune‐mediated hypersensitivity disorder of the ocular surface affecting 10%–20% of the global population. Current therapeutic options, while effective to some extent, are often limited by side effects and inconsistent efficacy.
Sanila Mughal   +7 more
wiley   +1 more source

以pimecrolimus藥膏治療類固醇玫瑰斑之開放性臨床試 驗評估其安全性與有效性

open access: yes, 2008
Background Steroid-induced rosacea-like eruption is characterized by facial rosacea-like dermatitis in patients that have been treated with topical steroids for relatively long periods.
CHU, CHIA-YU, 朱家瑜
core  

Analysis of care giver's assessment (pimecrolimus vs pruritus).

open access: yes, 2014
Analysis of care giver's assessment (pimecrolimus vs pruritus).
Youyu Sheng (545451)   +1 more
core   +1 more source

Pimecrolimus 1% cream in non-specific inflammatory recurrent balanitis

open access: yes, 2007
Background: Non-specific balanitis is a common inflammatory dermatosis with frequent relapses and considerable impact on male sexual life. Objective: To evaluate the efficacy and safety of pimecrolimus 1% cream in recurrent non-specific balanitis ...
Befon, A.   +6 more
core   +1 more source

Clinical Features and Therapeutic Outcomes in Pyoderma Gangrenosum: A Prospective Cohort Study

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 495-501, June 2026.
ABSTRACT Background Pyoderma gangrenosum (PG) is a rare neutrophilic dermatosis highly associated with systemic comorbidities. Accurate diagnosis and treatment remain challenging due to its rarity and clinical mimickers. Objectives To evaluate demographic, clinical features and treatment outcomes in patients referred with suspected PG at a tertiary ...
David Croitoru   +13 more
wiley   +1 more source

Pimecrolimus increases the expression of interferon-inducible genes that modulate human coronary artery cells proliferation

open access: yes, 2016
The pharmacodynamics of the loaded compounds defines clinical failure or success of a drug-eluting device. Various limus derivatives have entered clinics due to the observed positive outcome after stent implantation, which is explained by their ...
Sünwoldt, Juliane   +9 more
core   +1 more source

Sensitive Skin Syndrome in Children with Atopic Dermatitis: Pathogenesis and Management Features

open access: yesВопросы современной педиатрии, 2019
The atopic dermatitis (AD) is common skin disease and has significant impact on patients and their families quality of life. In recent years the term “sensitive skin" has been used more frequently. It is separate syndrome with subjective perception (such
Nikolay N. Murashkin   +8 more
doaj   +1 more source

Dual‐Responsive Chitosan‐Grafted PNIPAAm Hydrogel Eye Drop Incorporating Insulin‐Imprinted Microgels for Dry Eye Syndrome Treatment

open access: yesMacromolecular Bioscience, Volume 26, Issue 6, June 2026.
ABSTRACT Dry eye syndrome (DES) happens as a result of inadequate tear secretion or excessive evaporation, which leads to ocular surface irritation and damage. A major therapeutic challenge is maintaining effective drug concentrations, as topical formulations are rapidly cleared by blinking and tear turnover.
Masoumeh Alsadat Hosseini   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy